UNION CITY, Calif.,
July 19, 2011 /PRNewswire/ -- Abaxis,
Inc. (NasdaqGS: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, has scheduled a conference
call to discuss its financial results for the first quarter of
fiscal year 2012, ended June 30,
2011. The call will be at 4:15 p.m.
ET on Thursday, July 28, 2011.
The Company will report financial results for the first
quarter of fiscal year 2012 after the market closes on Thursday, July 28, 2011.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10002131, through August 3, 2011.
About Abaxis
Abaxis develops, manufactures and markets portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram (11.2
pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs or rotors, which contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system can
be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system provides
test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. The
veterinary business also provides to the animal health and research
market a line of hematology instruments for point-of-care complete
blood counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fibrinogen levels, a
handheld instrument for the rapid assessment of certain critical
care tests and rapid point-of-care tests for Heartworm infections
in dogs, Parvovirus and Giardia. Abaxis is also in the final stages
of building a full-service laboratory testing facility for
veterinarians, focusing on specialty and esoteric testing and
analysis. This state-of-the-art commercial laboratory will be
the hub of the Abaxis Veterinary Reference Laboratories (AVRL).
Contact:
|
Clint Severson
|
Lytham Partners, LLC
|
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz &
Robert Blum
|
|
|
Abaxis, Inc.
|
602-889-9700
|
|
|
510-675-6500
|
|
|
|
|
|
SOURCE Abaxis, Inc.